Menu

News

Melanoma in the News

Click here for the SMR Facebook page.

American Cancer Society and Melanoma Research Alliance Partner to Improve Immunotherapy Outcomes

Grants will fund research aimed at decreasing rare but serious side effects associated with checkpoint inhibitors

A new partnership between the American Cancer Society (ACS) and the Melanoma Research Alliance (MRA) will fund much needed research aimed at decreasing rare but serious, and at times even life-threatening, side effects associated with checkpoint inhibitors in hopes of increasing further cancer immunotherapy benefit to patients.

Read more

Newsletters

You can view our newsletters and commentaries by clicking the appropriate link on the left.